Provenge Cancer Vaccine: Can You Put a Price on Delaying
Death?
29 July 2010
By Courtney Hutchison, ABC News Medical Unit
Can you put a price tag on the life of a prostate cancer
patient?
With the advent of Provenge, the first-ever vaccine cancer
treatment, that tag has been set at about $23,000 per month of life
gained -- $93,000 in total for a treatment that extends life, on
average, by four months.
Given already skyrocketing health care costs, the
nearly-six-figure cost of Provenge has raised concerns among health
care experts, but to those men who have benefited from this
revolutionary new therapy, it's worth every penny.
Full article
DISCLAIMER
The links and content above are provided for your convenience to provide further information and do not constitute an endorsement by Bavarian Nordic. We have no control over the nature, content and availability of the sites that are being linked to and thus we assume no responsibility for the privacy practices on such websites.
